125 related articles for article (PubMed ID: 14679452)
1. Age distribution for T cell reactivity to vaccinia virus in a healthy population.
Hsieh SM; Pan SC; Chen SY; Huang PF; Chang SC
Clin Infect Dis; 2004 Jan; 38(1):86-9. PubMed ID: 14679452
[TBL] [Abstract][Full Text] [Related]
2. Induction of human T cell-mediated immune responses after primary and secondary smallpox vaccination.
Kennedy JS; Frey SE; Yan L; Rothman AL; Cruz J; Newman FK; Orphin L; Belshe RB; Ennis FA
J Infect Dis; 2004 Oct; 190(7):1286-94. PubMed ID: 15346340
[TBL] [Abstract][Full Text] [Related]
3. The persistence of humoral and cellular immunities more than three decades after smallpox vaccination.
Kim SH; Yeo SG; Park KH; Bang JW; Kim HB; Kim NJ; Jee Y; Cho H; Oh MD; Choe KW
Clin Microbiol Infect; 2007 Jan; 13(1):91-3. PubMed ID: 17184294
[TBL] [Abstract][Full Text] [Related]
4. Primary induction of human CD8+ cytotoxic T lymphocytes and interferon-gamma-producing T cells after smallpox vaccination.
Ennis FA; Cruz J; Demkowicz WE; Rothman AL; McClain DJ
J Infect Dis; 2002 Jun; 185(11):1657-9. PubMed ID: 12023773
[TBL] [Abstract][Full Text] [Related]
5. [Evaluation of residual immune response against human pox virus before and after revaccination in healthy volunteers].
Bricaire F; Combadière B; Rouleau E; Bossi P; Garin D; Lebrun-Vignes B; Autran B
Bull Acad Natl Med; 2006; 190(4-5):1035-46; discussion 1046-9. PubMed ID: 17195626
[TBL] [Abstract][Full Text] [Related]
6. Clinical and immunological responses to undiluted and diluted smallpox vaccine with vaccinia virus of Lister strain.
Hsieh SM; Chen SY; Sheu GC; Hung MN; Chou WH; Chang SC; Hsu KH
Vaccine; 2006 Jan; 24(4):510-5. PubMed ID: 16139395
[TBL] [Abstract][Full Text] [Related]
7. New data in a 200-year investigation.
Bray M
Clin Infect Dis; 2004 Jan; 38(1):90-1. PubMed ID: 14679453
[No Abstract] [Full Text] [Related]
8. Real time PCR for the assessment of CD8+ T cellular immune response after prophylactic vaccinia vaccination.
Trojan A; Rajeswaran R; Montemurro M; Mütsch M; Steffen R
J Clin Virol; 2007 Sep; 40(1):80-3. PubMed ID: 17644471
[TBL] [Abstract][Full Text] [Related]
9. Bioterrorism. Smallpox vaccinations: how much protection remains?
Cohen J
Science; 2001 Nov; 294(5544):985. PubMed ID: 11691969
[No Abstract] [Full Text] [Related]
10. Comparison of the safety and immunogenicity of ACAM1000, ACAM2000 and Dryvax in healthy vaccinia-naive adults.
Frey SE; Newman FK; Kennedy JS; Ennis F; Abate G; Hoft DF; Monath TP
Vaccine; 2009 Mar; 27(10):1637-44. PubMed ID: 19071184
[TBL] [Abstract][Full Text] [Related]
11. Human effector and memory CD8+ T cell responses to smallpox and yellow fever vaccines.
Miller JD; van der Most RG; Akondy RS; Glidewell JT; Albott S; Masopust D; Murali-Krishna K; Mahar PL; Edupuganti S; Lalor S; Germon S; Del Rio C; Mulligan MJ; Staprans SI; Altman JD; Feinberg MB; Ahmed R
Immunity; 2008 May; 28(5):710-22. PubMed ID: 18468462
[TBL] [Abstract][Full Text] [Related]
12. Enhanced immunogenicity and protective effect conferred by vaccination with combinations of modified vaccinia virus Ankara and licensed smallpox vaccine Dryvax in a mouse model.
Meseda CA; Garcia AD; Kumar A; Mayer AE; Manischewitz J; King LR; Golding H; Merchlinsky M; Weir JP
Virology; 2005 Sep; 339(2):164-75. PubMed ID: 15993917
[TBL] [Abstract][Full Text] [Related]
13. Immune responses to vaccinia and influenza elicited during primary versus recent or distant secondary smallpox vaccination of adults.
Treanor J; Wu H; Liang H; Topham DJ
Vaccine; 2006 Nov; 24(47-48):6913-23. PubMed ID: 17014939
[TBL] [Abstract][Full Text] [Related]
14. Dose-related effects of smallpox vaccine.
Frey SE; Newman FK; Cruz J; Shelton WB; Tennant JM; Polach T; Rothman AL; Kennedy JS; Wolff M; Belshe RB; Ennis FA
N Engl J Med; 2002 Apr; 346(17):1275-80. PubMed ID: 11923489
[TBL] [Abstract][Full Text] [Related]
15. Determination of immunity to vaccinia virus by using diluted inactivated vaccinia vaccine solution for skin testing.
Somekh E; Smetana Z; Tanay A; Dalal I; Babai I; Mendelson E
Vaccine; 2004 Dec; 23(3):321-4. PubMed ID: 15530675
[TBL] [Abstract][Full Text] [Related]
16. Immunity and immunological memory following smallpox vaccination.
Amanna IJ; Slifka MK; Crotty S
Immunol Rev; 2006 Jun; 211():320-37. PubMed ID: 16824139
[TBL] [Abstract][Full Text] [Related]
17. Distinct time effects of vaccination on long-term proliferative and IFN-gamma-producing T cell memory to smallpox in humans.
Combadiere B; Boissonnas A; Carcelain G; Lefranc E; Samri A; Bricaire F; Debre P; Autran B
J Exp Med; 2004 Jun; 199(11):1585-93. PubMed ID: 15184506
[TBL] [Abstract][Full Text] [Related]
18. Boosting T cell-mediated immunity to tyrosinase by vaccinia virus-transduced, CD34(+)-derived dendritic cell vaccination: a phase I trial in metastatic melanoma.
Di Nicola M; Carlo-Stella C; Mortarini R; Baldassari P; Guidetti A; Gallino GF; Del Vecchio M; Ravagnani F; Magni M; Chaplin P; Cascinelli N; Parmiani G; Gianni AM; Anichini A
Clin Cancer Res; 2004 Aug; 10(16):5381-90. PubMed ID: 15328176
[TBL] [Abstract][Full Text] [Related]
19. Highly attenuated smallpox vaccine protects mice with and without immune deficiencies against pathogenic vaccinia virus challenge.
Wyatt LS; Earl PL; Eller LA; Moss B
Proc Natl Acad Sci U S A; 2004 Mar; 101(13):4590-5. PubMed ID: 15070762
[TBL] [Abstract][Full Text] [Related]
20. Identification of vaccinia CD8+ T-cell epitopes conserved among vaccinia and variola viruses restricted by common MHC class I molecules, HLA-A2 or HLA-B7.
Terajima M; Cruz J; Leporati AM; Demkowicz WE; Kennedy JS; Ennis FA
Hum Immunol; 2006 Jul; 67(7):512-20. PubMed ID: 16829305
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
